Mortality among pediatric hematopoietic stem cell transplantation patients: Report from a single center in southern Brazil.
Tyane de Almeida Pinto JardimBruno Araújo JardimGiovanni Luís BredaCarmem BonfimSonia Maria RaboniPublished in: Pediatric transplantation (2021)
The prognosis in allogeneic HSCT is influenced by the origin of the stem cells, the presence of acute GVHD and the occurrence of infectious diseases. Studies that evaluate pediatric individuals undergoing HSCT and analyze their mortality profile, can improve the management of these patients, possibly leading to a reduction in TRM.
Keyphrases
- end stage renal disease
- stem cells
- ejection fraction
- newly diagnosed
- chronic kidney disease
- peritoneal dialysis
- infectious diseases
- prognostic factors
- cardiovascular events
- stem cell transplantation
- acute myeloid leukemia
- type diabetes
- hepatitis b virus
- coronary artery disease
- extracorporeal membrane oxygenation
- high dose
- cell therapy